Neodymium: YAG transscleral cyclocoagulation in human eyes.
Transscleral neodymium: YAG (Nd:YAG) cyclocoagulation has been successfully used to lower intraocular pressure (IOP) in rabbits. The authors treated 24 patients with uncontrolled glaucoma using the thermal mode of the Nd:YAG laser. The patients were followed for a mean of 8.8 months. A total of 62.5% of treated eyes achieved an IOP on last follow-up of 25 mmHg or less. The mean pretreatment pressure was 47.2 mmHg and the mean posttreatment pressure was 25.7 mmHg (P = 0.009). The complications and potential clinical usefulness of this mode of therapy are discussed.
Devenyi
R G
RG
Department of Ophthalmology, Toronto General Hospital, Ontario, Canada.
Trope
G E
GE
Hunter
W H
WH
Badeeb
O
O
D005069:Evaluation Studies as Topic; D005901:Glaucoma / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D053685:Laser Therapy / Q000009:adverse effects; D008028:Light Coagulation / Q000009:adverse effects; D013508:Ophthalmologic Surgical Procedures; D011184:Postoperative Period; D012086:Reoperation; D014792:Visual Acuity